COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 2047: Articles 20461-20470  | Next

Systematic evaluation of transcriptomic disease risk and diagnostic biomarker overlap between COVID-19 and tuberculosis: a patient-level meta-analysis
Sheerin, D., Abhimanyu, A., Wang, X., Johnson, W. E., Coussens, A.
10.1101/2020.11.25.20236646 — Posted: 2020-11-26
Global analysis of protein-RNA interactions in SARS-CoV-2 infected cells reveals key regulators of infection
Kamel, W., Noerenberg, M., Cerikan, B., Chen, H., Järvelin, A. I., Kammoun, M., Lee, J., Shuai, N., Garcia-Moreno, M., Andrejeva, A., Deery, M. J., Neufeldt, C. J., Cortese, M., Knight, M. L., Lilley, K. S., Martinez, J., Davis, I., Bartenschlager, R., Mohammed, S., Castello, A.
10.1101/2020.11.25.398008 — Posted: 2020-11-25
3D8, a nucleic acid-hydrolyzing scFv, confers antiviral activity against SARS-CoV-2 and multiple coronaviruses in vitro
Lee, G., Budhathoki, S., Choi, H. S., Oh, K.-j., Lee, G.-Y., Ham, Y. K., Kim, Y. J., Lim, Y. R., Hoang, P. T., Lee, Y., Lim, S.-W., Kim, J.-M., Cho, S., Song, J.-W., Lee, S., Kim, W.-K.
10.1101/2020.11.25.398909 — Posted: 2020-11-25
SARS-CoV-2 utilizes a multipronged strategy to suppress host protein synthesis
Finkel, Y., Gluck, A., Winkler, R., Nachshon, A., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., Yahalom-Ronen, Y., Tamir, H., Ulitsky, I., Israely, T., Paran, N., Schwartz, M., Stern-Ginossar, N.
10.1101/2020.11.25.398578 — Posted: 2020-11-25
Evolutionary analysis of SARS-CoV-2 spike protein for its different clades
Pereson, M. J., Flichman, D., Martinez, A., Bare, P., Garcia, G., Di Lello, F.
10.1101/2020.11.24.396671 — Posted: 2020-11-25 Discussion: Onsite | Offsite
Double Lock of a Potent Human Monoclonal Antibody against SARS-CoV-2
Wang, X., Qin, C., Wang, Y., Rao, Z., Xie, L., Zhu, L., Deng, Y.-Q., Zhang, R.-r., Cui, Z., Sun, C.-Y., Fan, C.-F., Xing, X., Huang, W., Chen, Q., Zhang, N.-N., Ye, Q., Cao, T.-S., Wang, N., Wang, L., Cao, L., Wang, H., Kong, D., Ma, J., Luo, C., Zhang, Y., Nie, J., Sun, Y., Lv, Z., Shaw, N., Li, Q., Li, X.-F., Hu, J.
10.1101/2020.11.24.393629 — Posted: 2020-11-25
A Nasal Spray Solution of Grapefruit Seed Extract plus Xylitol Displays Virucidal Activity Against SARS-Cov-2 In Vitro
Ferrer, G. A., Betancour, A., Go, C. C., Vazquez, H., Westover, J. B., Cagno, V., Tapparel, C., Sanchez-Gonzalez, M. A.
10.1101/2020.11.23.394114 — Posted: 2020-11-25
Nurses' burnout and associated risk factors during the COVID-19 pandemic: a systematic review and meta-analysis
Galanis, P. A., Vraka, I., Fragkou, D., Bilali, A., Kaitelidou, D.
10.1101/2020.11.24.20237750 — Posted: 2020-11-25
Analytical and diagnostic performances of a high-throughput immunoassay for SARS-CoV-2 IgM and IgG
Padoan, A., Cosma, C., Zaupa, P., Plebani, M.
10.1101/2020.11.20.20235267 — Posted: 2020-11-24
Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
Hellewell, J., Russell, T. W., The SAFER Investigators and Field study team, , The Crick COVID-19 Consortium, , CMMID COVID-19 Working Group, , Beale, R., Kelly, G., Houlihan, C., Nastouli, E., Kucharski, A. J.
10.1101/2020.11.24.20229948 — Posted: 2020-11-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).